Balanced news tone
News Sentiment
HLN sentiment intelligence
Haleon plc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
78/100 classification confidence.
directly relevant articles
high-authority source matches
-1.9% over one week, -3.6% over four weeks, trend inactive, and near fair-value range.
Haleon (NYSE: HLN) details 14.3M-share buyback and new voting capital
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Haleon (NYSE: HLN) details 14.3M-share buyback and new voting capital
- Tone
- Positive 62/100
- Event
- Capital return
- Published
- 22 Jun 2026 10:42
- Source
- Stock Titan
REG - Haleon PLC - Transactions in Own Shares
Haleon PLC announced the purchase of 14,288,204 ordinary shares for cancellation under its share buyback programme, initially announced on March 12, 2026. The aggregated information provides details of share purchases between June 16 and June 18, 2026, across different exchanges,
- Tone
- Positive 70/100
- Event
- Capital return
- Published
- 22 Jun 2026 06:10
- Source
- TradingView
Haleon shares slip into the weekend after Redburn downgrade tests recovery hopes
Haleon's shares slipped after Redburn downgraded the stock to Neutral with a 365p price target, raising doubts about the company's U.S. recovery. Despite a £500 million share buyback program offering some support, the company faces challenges with cautious U.S. shoppers and slow
- Tone
- Negative 37/100
- Event
- Capital return
- Published
- 20 Jun 2026 19:39
- Source
- Bez Kabli
Haleon (HLN) Issues Voluntary Nationwide Recall for Specific Gas-X Extra Strength Softgels
Haleon (HLN) has initiated a voluntary nationwide recall for specific lots of its Gas-X Extra Strength Softgels due to potential contamination from a diluted propylene glycol-based coolant. Although no adverse health events have been reported, the company is taking precautionary
- Tone
- Negative 30/100
- Event
- Regulatory and legal
- Published
- 19 Jun 2026 17:10
- Source
- Market source
Haleon shares nudge up with brokers mixed on U.S. recovery view
Haleon shares saw a slight increase even as brokers presented mixed views on the potential for a U.S. recovery, with Rothschild & Co Redburn cutting its rating and Morgan Stanley trimming its price target. Investors are closely watching for Haleon's first-half results on July 30
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 19 Jun 2026 13:10
- Source
- Bez Kabli
Haleon PLC (HLN) Institutional Confidence
Haleon PLC (HLN) has an institutional shareholding score of 3.00, placing it 94th out of 157 in the Pharmaceuticals industry. Institutional investors hold 12.97% of shares, a 5.63% increase quarter-over-quarter. First Eagle Investment is the largest institutional shareholder, hol
- Tone
- Positive 65/100
- Event
- Market update
- Published
- 19 Jun 2026 08:11
- Source
- TradingKey
Haleon PLC (HLN) Earnings Forecast: Future EPS & Revenue Growth Estimates
Haleon PLC (HLN) has an earnings forecast score of 7.60, ranking 98 out of 157 in the Pharmaceuticals industry, with an average analyst price target of $11.50. Based on ratings from 5 analysts, the consensus is a "Buy" recommendation for the stock. The article highlights key fina
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 18 Jun 2026 20:39
- Source
- TradingKey
One Haleon Insider Has Reduced Their Stake
One Haleon insider, CEO Brian McNamara, sold UK£464k worth of shares in the last year, although this sale was at a price above the current share price. While there was some insider buying, the selling significantly outweighed the buying, suggesting some insiders might believe the
- Tone
- Negative 38/100
- Event
- Deals and strategy
- Published
- 18 Jun 2026 16:40
- Source
- Simply Wall Street
Haleon PLC (HLN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution
This article provides a detailed breakdown of Haleon PLC's (HLN) revenue by business segment and geographical region for the fiscal year 2023. It highlights Oral Health, Pain Relief, and Respiratory Health as key contributors to revenue, alongside significant regional contributio
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 18 Jun 2026 15:40
- Source
- TradingKey
Rothschild & Co Redburn Downgrades Haleon to Neutral From Buy, Adjusts PT to $4.90 From $5.43
- Tone
- Positive 58/100
- Event
- Market update
- Published
- 18 Jun 2026 10:19
- Source
- MT Newswires
Haleon PLC (HLN) Dividends & Stock Splits: Historical Payouts and Event Timeline
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 09:59
- Source
- TradingKey
Haleon slips after Redburn downgrade with eyes on U.S. and July earnings
Haleon's shares slipped after Rothschild & Co Redburn downgraded the stock to Neutral, impacting its position on the FTSE 100. Investors are concerned about sales growth prospects, particularly a rebound in North America and overall volume increases, ahead of the H1 2026 results
- Tone
- Negative 37/100
- Event
- Earnings
- Published
- 16 Jun 2026 14:40
- Source
- Bez Kabli
Haleon plc Stock 12‑Month Price Target Cut to $11.2, Implies 23% Upside
Haleon plc's average 12-month price target has been adjusted to $11.2 from $11.27, according to estimates from 15 analysts.
- Tone
- Positive 63/100
- Event
- Analyst action
- Published
- 16 Jun 2026 13:40
- Source
- TradingView
Haleon buys back 565,285 shares for cancellation on London Stock Exchange
Haleon plc announced it purchased and cancelled 565,285 ordinary shares as part of its ongoing share buyback program. The transactions occurred on June 8, 2026, on the London Stock Exchange, with a volume weighted average price of 331.9552 pence per share. Following these transac
- Tone
- Positive 66/100
- Event
- Capital return
- Published
- 16 Jun 2026 07:39
- Source
- Investing.com
Understanding Momentum Shifts in (HLN)
This article analyzes Haleon Plc (HLN) using AI models, identifying a near-term strong sentiment but a neutral mid and long-term outlook. It highlights a significant 22.7:1 risk-reward setup targeting a 7.6% gain and outlines specific institutional trading strategies including po
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 15 Jun 2026 20:40
- Source
- Stock Traders Daily
Haleon slips as company hints at further buybacks, eyes stay on July earnings
Haleon's stock slipped 0.12% in London to 336.40p, with investors remaining cautious after a rocky start to 2026, despite hints of further share buybacks. The company canceled over 565,000 shares from its 2026 buyback program and is actively pursuing a £500 million buyback, funde
- Tone
- Negative 41/100
- Event
- Capital return
- Published
- 15 Jun 2026 14:39
- Source
- Bez Kabli
Haleon (NYSE: HLN) repurchases and cancels 565,285 shares in buyback
Haleon plc announced it repurchased and canceled 565,285 ordinary shares on June 8, 2026, as part of its share buyback program initiated on March 12, 2026. The shares were bought on the London Stock Exchange at prices ranging from 330.5000p to 335.0000p, with a volume-weighted av
- Tone
- Positive 65/100
- Event
- Capital return
- Published
- 15 Jun 2026 09:39
- Source
- Stock Titan
Haleon stock moves higher as buybacks, U.S. momentum, July report watched
Haleon's stock rose 0.84% on Friday, driven by an ongoing share buyback program and strong performance in its Oral Health division, particularly in North America. Investors are anticipating the company's H1 2026 results on July 30 for further indications of growth, as risks like
- Tone
- Positive 59/100
- Event
- Capital return
- Published
- 13 Jun 2026 20:41
- Source
- Bez Kabli
Haleon plc Stock (GB00BMX86B70): Valuation and fundamentals in focus
The article provides an overview of Haleon plc (GB00BMX86B70), a global consumer health company, focusing on its market valuation, fundamental strengths, and dividend profile. It highlights Haleon's status as a large-cap defensive play within the healthcare sector, its diverse po
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 13 Jun 2026 17:41
- Source
- AD HOC NEWS
Haleon to build new India Plant in Madhya Pradesh
Haleon plans to construct a new manufacturing plant in Pithampur, Madhya Pradesh, to produce oral health products under the Sensodyne brand. This investment highlights India's strategic importance as a growth market for Haleon, aiming to meet rising domestic and international dem
- Tone
- Positive 82/100
- Event
- Market update
- Published
- 13 Jun 2026 11:39
- Source
- Manufacturing Today India
Haleon Stock Moves Up After £175m India Bet
Haleon's stock moved up after the company announced plans to invest £175 million in a new oral-health plant in India, aiming to boost long-term growth and rural distribution. While the India initiative is a strategic move for the consumer health giant, its impact on earnings is e
- Tone
- Positive 63/100
- Event
- Earnings
- Published
- 12 Jun 2026 15:09
- Source
- Bez Kabli
Haleon Announces ~₹2000 Crore Total Investment to Set Up its First Manufacturing Facility in India
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Jun 2026 08:30
- Source
- PR Newswire
Haleon completes purchase of 16.6 million shares for cancellation
Haleon plc announced it has completed the purchase and cancellation of 16,585,448 ordinary shares as part of its share buyback program. These transactions occurred between June 1 and June 4 across various exchanges, with prices ranging from 317.9 pence to 334.1 pence per share. F
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 09 Jun 2026 16:40
- Source
- Investing.com UK
Haleon plc stock (GB00BMX86B70): Consumer health specialist updates investors after Q1 2026 trading
Haleon plc has released its Q1 2026 trading update, affirming its full-year guidance and providing insights into its growth, margins, and cash generation. The consumer health specialist, listed on both the London Stock Exchange and NYSE, reported continued strength in oral health
- Tone
- Positive 64/100
- Event
- Guidance
- Published
- 09 Jun 2026 15:23
- Source
- AD HOC NEWS
HLN Stock Price and Chart — NYSE:HLN
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jun 2026 07:00
- Source
- TradingView
Sensodyne Maker Haleon To Build First India Plant In Madhya Pradesh With Rs 2,000-Crore Investment
Haleon, the maker of Sensodyne, plans to invest nearly Rs 2,000 crore (£175 million) to establish its first manufacturing unit in India, located in Pithampur, Madhya Pradesh. This greenfield facility will focus on oral care products, aiming to start operations by 2029-30 and cate
- Tone
- Positive 73/100
- Event
- Market update
- Published
- 09 Jun 2026 06:09
- Source
- Swarajyamag
Haleon (NYSE: HLN) reports June 2026 share buyback activity
Haleon plc announced significant share buyback activity between June 1 and June 4, 2026, repurchasing 16,585,448 ordinary shares for cancellation. This action is part of a buyback program initiated on March 12, 2026, and has resulted in an updated registered share capital and rev
- Tone
- Positive 63/100
- Event
- Capital return
- Published
- 08 Jun 2026 19:40
- Source
- Stock Titan
Haleon Plc (HLN) Stock Analysis: Analysts See A 28.73% Upside For This Healthcare Giant
Haleon Plc (HLN), a leading healthcare company, is attracting investor attention with a potential 28.73% upside based on analyst target prices. The company, known for brands like Sensodyne and Advil, boasts a healthy return on equity and offers a 2.12% dividend yield, complemente
- Tone
- Positive 72/100
- Event
- Analyst action
- Published
- 08 Jun 2026 16:09
- Source
- DirectorsTalk Interviews
Haleon falls Monday, underperforms market
Haleon PLC shares dropped 1.78% to £3.31 on Monday, underperforming the FTSE 100 Index which rose slightly. The company's stock closed 20.45% below its 52-week high reached in February.
- Tone
- Negative 30/100
- Event
- Market update
- Published
- 08 Jun 2026 12:05
- Source
- MarketWatch
Haleon to Invest $233.1 Million in India Oral Care Expansion
- Tone
- Positive 58/100
- Event
- Market update
- Published
- 08 Jun 2026 10:13
- Source
- MT Newswires